第三届监事会第十七次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 东瑞食品集团股份有限公司（下称"公司"）第三届监事会第十七次会议于 2025年11月28日以现场会议方式在公司会议室召开。参加会议的应出席监事3 名，实际出席监事3名，符合《中华人民共和国公司法》及《公司章程》的规定。 一、会议议案： （一）关于续聘2025年度审计机构的议案。 证券代码：001201 证券简称：东瑞股份 公告编号：2025-043 东瑞食品集团股份有限公司 监事会 二〇二五年十一月二十九日 二、会议采用记名投票的方式进行表决，经与会的监事表决，审议通过了 以下决议： （一）审议关于续聘2025年度审计机构的议案 公司拟续聘致同会计师事务所（特殊普通合伙）为公司2025年度审计机构， 承办公司2025年度审计业务。本议案内容详见公司于2025年11月29日在巨潮资 讯网（www.cninfo.com.cn）披露的《关于续聘公司2025年度审计机构的公告》 （公告编号：2025-046）。 表决结果：同意3票，反对0票，弃权0票。 本议案尚需提交2025年第一次临时 ...

证券代码：001201 证券简称：东瑞股份 公告编号：2025-044 东瑞食品集团股份有限公司 第三届董事会第十八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 东瑞食品集团股份有限公司（下称"公司"）于2025年11月28日以现场+ 通讯会议方式召开第三届董事会第十八次会议。召开本次会议的通知及相关会 议资料已于2025年11月26日通过书面、电子邮件等方式送达各位董事、监事和 高级管理人员。 本次会议应出席董事9名，实到董事9名，会议有效表决票数为9票。本次董 事会的召开程序符合《中华人民共和国公司法》及《公司章程》的规定。公司 全体监事及相关高级管理人员列席了本次会议。会议由袁建康先生主持。 一、会议议案： （一）关于修订《公司章程》的议案； （二）关于修订及制定公司部分治理制度的议案； （六）关于召开2025年第一次临时股东大会的议案。 二、会议采用记名投票的方式进行表决，经与会的董事表决，审议通过了 以下决议： （一）审议关于修订《公司章程》的议案 《公司章程》的具体修订内容详见公司于2025年11月29日在巨潮资讯网 （www.c ...

Core Viewpoint - The article discusses how Dongrui Food Group is leveraging the "media+" initiative to transform the livestock industry in Heyuan from a "production-driven" model to a "consumption-driven" one, aiming for high-quality development and market expansion [5][16][96]. Group 1: Company Initiatives - Dongrui Food Group is focusing on a "full industry chain" layout for pig farming, planning to establish its first deep processing production line in Heyuan by 2026, targeting an output value of 100 million yuan within 2-3 years [6][64]. - The company is developing an ecological "air pig farm" model, which has the potential to generate over 10 million yuan in circular economy revenue annually through waste recycling and energy production [22][30]. - Dongrui is also exploring a "company + family farm" model to increase pig output by 500,000 heads annually, benefiting local farmers by sharing resources and reducing risks [44][50]. Group 2: Industry Development - Heyuan City has set a goal of achieving over 10 billion yuan in agricultural output value, with 14 national-level standardized breeding farms and 8 provincial-level modern beautiful pastures established to support this initiative [71]. - The "media+" initiative aims to enhance the sales channels for agricultural products, addressing the current challenge of insufficient consumer demand in the livestock sector [76][78]. - The action plan includes eight key tasks such as channel expansion, value creation, and cultural promotion to strengthen the market position of Heyuan's agricultural products [80][82]. Group 3: Market Strategy - Dongrui Food Group is collaborating with local agricultural institutions to develop processed meat products, achieving sales of over 60 tons through cold chain distribution in the Greater Bay Area [62][64]. - The company plans to participate actively in the "media+" initiative to enhance the branding and sales channels for Heyuan's livestock products, aiming to facilitate a smoother connection between production and consumption [94][96].

Market Overview - The aquaculture sector experienced a decline of 1.58% on November 21, with Huaying Agriculture leading the drop [1] - The Shanghai Composite Index closed at 3834.89, down 2.45%, while the Shenzhen Component Index closed at 12538.07, down 3.41% [1] Stock Performance - Huaying Agriculture (002321) closed at 3.24, down 10.00% with a trading volume of 1.5762 million shares and a turnover of 517 million yuan [1] - Tianyu Biological (603717) closed at 8.44, down 8.76% with a trading volume of 209,500 shares and a turnover of 180 million yuan [1] - Yike Food (301116) closed at 12.20, down 8.20% with a trading volume of 271,100 shares and a turnover of 338 million yuan [1] - Other notable declines include Fucheng Co. (600965) down 4.95%, Tianbang Food (002124) down 4.23%, and Dongrui Co. (001201) down 4.07% [1] Capital Flow - The aquaculture sector saw a net outflow of 572 million yuan from institutional investors, while retail investors contributed a net inflow of 261 million yuan [1] - The table of capital flow indicates that Xiaoming Co. (300967) had a net outflow of 912.89 million yuan from institutional investors [2] - Jingqi Zhino (000048) experienced a net inflow of 856.43 million yuan from institutional investors [2] - Shengnong Development (002299) had a net inflow of 134.24 million yuan from institutional investors [2]

每经AI快讯，有投资者在投资者互动平台提问：贵司估计2025年度自营出口供港生猪数量多少万？供 货出口生猪数量多少万？ 东瑞股份（001201.SZ）11月18日在投资者互动平台表示，预计公司2025年全年供港澳活大猪约26万 头，其中自营出口约21万头，供货出口约5万头。 （文章来源：每日经济新闻） ...

人民财讯11月18日电，东瑞股份（001201）11月18日在互动平台表示，预计公司2025年全年供港澳活大 猪约26万头，其中自营出口约21万头，供货出口约5万头。 ...

Core Viewpoint - Dongrui Co., Ltd. (001201.SZ) expects to supply approximately 260,000 live pigs to Hong Kong and Macau in 2025, with self-operated exports accounting for about 210,000 pigs and supply exports for about 50,000 pigs [1] Group 1 - The company anticipates a total supply of 260,000 live pigs to Hong Kong and Macau in 2025 [1] - Self-operated exports are projected to be around 210,000 pigs [1] - Supply exports are expected to be approximately 50,000 pigs [1]

Group 1: China Construction - The total new contracts signed by China Construction from January to October reached 3.61 trillion yuan, representing a year-on-year increase of 1% [1] Group 2: Changyuan Power - Changyuan Power's subsidiary received approval for the 100MW wind power project in Songzi, Hubei [2] Group 3: China Metallurgical Group - China Metallurgical Group reported a total new contract amount of 845.07 billion yuan from January to October, a decrease of 11.8% year-on-year, while overseas contracts increased by 7.3% to 71.16 billion yuan [4] Group 4: Shapuaisi - Shapuaisi received approval for clinical trials of deoxycorticosterone ketone solution, intended for use during cataract surgery [5] Group 5: Jianfeng Group - Jianfeng Group's subsidiary received approval for clinical trials of a new drug for treating advanced non-squamous non-small cell lung cancer [7] Group 6: Chongqing Steel - Chongqing Steel announced the resignation of its president Meng Wenwang due to work adjustments [8] Group 7: Tianma Technology - Tianma Technology reported an output of approximately 1732.99 tons of eel in October, with a total output of about 15218.73 tons from January to October [10] Group 8: Qingyuan Co. - Qingyuan Co.'s controlling shareholder reduced holdings of convertible bonds by 685,400 units, accounting for 13.71% of the total issuance [11] Group 9: Spring Airlines - Spring Airlines reported a passenger turnover of 506,200.49 million kilometers in October, a year-on-year increase of 20.06% [12] Group 10: China Merchants Port - China Merchants Port reported a total container volume of 17.1714 million TEUs from January to October, a year-on-year increase of 5.1% [13] Group 11: Yangdian Technology - Yangdian Technology announced a change in control following a share transfer [15] Group 12: Wanfu Biology - Wanfu Biology decided to postpone the implementation of its Knowledge City production base project [16] Group 13: Iwu Biology - Iwu Biology terminated the research project for a specific drug, which will reduce its 2025 net profit by approximately 333.79 million yuan [17] Group 14: Hainan Rubber - Hainan Rubber received an insurance payout of 22.9241 million yuan due to revenue loss from rubber price fluctuations [19] Group 15: Xinjiang Tianye - Xinjiang Tianye plans to establish a joint venture with Tianchi Energy to develop coal chemical projects [20] Group 16: China Coal Energy - China Coal Energy's executive director and president Zhao Rongzhe resigned due to reaching retirement age [22] Group 17: Huading Co. - Huading Co. received approval for a stock issuance to specific investors from the Shanghai Stock Exchange [24] Group 18: Zhongmu Co. - Zhongmu Co. decided to waive its right of first refusal for a 4.04% stake in a subsidiary [25] Group 19: Tianlong Co. - Tianlong Co. reported that its subsidiary's stock issuance was approved by the Beijing Stock Exchange [26] Group 20: Hualan Co. - Hualan Co.'s subsidiary plans to invest 20 million yuan in a biotechnology company [27] Group 21: Haichen Pharmaceutical - Haichen Pharmaceutical received a drug registration certificate for a new injection [28] Group 22: Aier Eye Hospital - Aier Eye Hospital plans to invest 300 million yuan in wealth management products [29] Group 23: Xiamen Engineering Machinery - Xiamen Engineering Machinery announced a planned share reduction by a major shareholder [30] Group 24: Guotai Group - Guotai Group successfully acquired 100% of a mining technology company for 110.1 million yuan [31] Group 25: Wanfeng Aowei - Wanfeng Aowei reached a settlement regarding an arbitration matter with a subsidiary [32] Group 26: Taihe Technology - Taihe Technology is undergoing technical upgrades for its ethylene carbonate project [33] Group 27: Renhe Pharmaceutical - Renhe Pharmaceutical's controlling shareholder plans to reduce holdings by 0.21% [34] Group 28: Changshu Bank - Changshu Bank's second-largest shareholder increased its stake to 3.98% [35] Group 29: Overseas Chinese Town A - Overseas Chinese Town A reported a 57% decrease in contract sales in October [36] Group 30: Canadian Solar - Canadian Solar's controlling shareholder expects total revenue of 1.3 to 1.5 billion USD in Q4 2025 [38] Group 31: Zhonggong Education - Zhonggong Education's controlling shareholder's shares will be auctioned due to a loan dispute [40] Group 32: Aikexibo - Aikexibo's shareholders plan to reduce their holdings by up to 3% [42] Group 33: Wanhua Chemical - Wanhua Chemical's shareholder plans to reduce holdings by up to 0.5% [44] Group 34: Jujie Microfiber - Jujie Microfiber's controlling shareholder plans to reduce holdings by up to 2% [45] Group 35: Wangsu Technology - Wangsu Technology's shareholder plans to reduce holdings by up to 1% [46] Group 36: Tianli Lithium Energy - Tianli Lithium Energy received a patent for lithium-ion battery materials [47] Group 37: Heshun Electric - Heshun Electric won a 40 million yuan project for energy storage services [49] Group 38: Changchun High-tech - Changchun High-tech's subsidiary received FDA approval for a clinical trial of a new drug [51] Group 39: Dongrui Co. - Dongrui Co. received an additional export quota for live pigs to Hong Kong [52] Group 40: Zhongwei Co. - Zhongwei Co. set the H-share issuance price at 34 HKD per share [53] Group 41: Fospower Technology - Fospower Technology plans to invest in a lithium sulfide project with partners [54]

Group 1: Company Performance - SMIC reported a revenue of 17.162 billion yuan in Q3 2025, a year-on-year increase of 9.9%, with a net profit of 1.51 billion yuan, up 43.1% year-on-year. For the first three quarters, revenue reached 49.51 billion yuan, growing 18.2%, and net profit was 3.81 billion yuan, an increase of 41.1% year-on-year [1] - BoRui Pharma's BGM1812 injection has received clinical trial approval for weight loss indications, with no similar targeted formulations approved globally [2] - Li Zhong Group's subsidiaries received project confirmations for aluminum alloy wheels from major international automotive manufacturers, with expected total sales of approximately 1.135 billion yuan [4] Group 2: Corporate Actions - Kanda New Materials announced the termination of the acquisition of equity in North One Semiconductor due to unmet progress expectations and lack of consensus among parties [3] - Lide Man plans to acquire 70% of Xiansheng Xiangrui for 1.733 billion yuan, aiming to enter the bioproducts industry [9] - Arctech's controlling shareholder CSIQ expects total revenue of 1.3 to 1.5 billion USD in Q4 2025, with a gross margin of 14% to 16% [6] Group 3: Market Activity - Taihe Technology's VC project phase two construction will be adjusted based on phase one market expansion, indicating some uncertainty [5] - Hezhong China has experienced significant stock price fluctuations, with a cumulative increase of 230.84% over 12 out of 13 trading days, leading to potential application for trading suspension if abnormal price increases continue [7][8]

证券日报网讯 11月13日晚间，东瑞股份发布公告称，公司于近日收到广东省商务厅来函《广东省商务 厅关于追加东瑞食品集团股份有限公司等3家企业2025年度供港澳活大猪出口配额的函》（粤商务管函 〔2025〕116号），主要内容如下：根据《广东省商务厅关于下达2025年度供港澳活畜禽配额的通知》 （粤商务管函〔2024〕154号）确定的配额分配原则及公司来函申请，现追加东瑞食品集团股份有限公 司2025年度供港活大猪配额5，189头。 （文章来源：证券日报） ...